Cipla Acquires South African Pharmaceutical Company Mirren
Cipla Medpro South Africa (Pty) Limited (Cipla Medpro), wholly owned subsidiary of Cipla Limited, India (Cipla) and South Africa's fourth-largest pharmaceutical company in the private sector, announced its plans to acquire a 100% stake in Mirren (Pty) Limited (Mirren). Mirren is a South African over-the-counter (OTC) pharmaceutical manufacturer and distributor, which has been in operations for 35 years. The transaction is subject to the approval by the Competition Commission of South Africa.
Paul Miller, CEO of Cipla South Africa, said that once approved, the transaction will enhance Cipla's current OTC portfolio, by adding Mirren's well-established brands such as Bronco! cough syrup, Coryx, Tensopyn, and Ultimag. This deal will also increase Cipla's local manufacturing footprint.